Aberrations of chromosome 13q in gastrointestinal stromal tumors: Analysis of 91 cases by fluorescence in situ hybridization (FISH)

Diagnostic Molecular Pathology

Volumn 18, Issue 2, 2009, Pages 72-80

  Zhou, Weixun ^a,b   Zeng, Xuan ^a,b   Liu, Tonghua ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Chromosomal instability; Chromosome 13q; GIST; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

KRUPPEL LIKE FACTOR 5; POTASSIUM CHANNEL; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; ASSOCIATION; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER RISK; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME IDENTIFICATION; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH; TUMOR VOLUME; ANEUPLOIDY; CHINA; CHROMOSOME 13; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANEUPLOIDY; CHINA; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67650001702     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318181fa1f     Document Type: Article

References (38)

1. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002; 33:459-465. (Pubitemid 34747864)
2. Tryggvason G, Gislason HG, Magnusson MK, et al. Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289-293.
3. DeMatteo RP, Lewis JJ, Leung D. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51-58. (Pubitemid 30043939)
4. Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002;20:3898-3905. (Pubitemid 35050845)
5. Inoue T, Suzuki T, Nakagawa K, et al. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times. Pathol Int. 2004;54:196-200. (Pubitemid 38698132)
6. Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol. 2002;33:484-495.
7. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299: 708-710. (Pubitemid 36159485)
8. Chen Y, Tzeng CC, Liou CP, et al. Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors. J Biomed Sci. 2004;11:65-71. (Pubitemid 38142354)
9. El-Rifai W, Sarlomo-Rikala M, Miettinen M, et al. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer. 2000;27:387-391. (Pubitemid 30127627)
10. Lasota J, Wozniak A, Kopczynski J, et al. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Lab Invest. 2005;85:237-247. (Pubitemid 40208927)
11. Miettinen M, El-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33:478-483. (Pubitemid 34747866)
12. Gunawan B, Bergmann F, Hoer J, et al. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol. 2002;33:316-321. (Pubitemid 34461465)
13. Nakamura N, Yamamoto H, Yao T, et al. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol. 2005;36:828-837. (Pubitemid 41112040)
14. Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol. 2001;8:50-59. (Pubitemid 32140424)
15. Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 2003;43:118-126. (Pubitemid 36963155)
16. Bucher P, Taylor S, Villiger P, et al. Are there any prognostic factors for small intestinal stromal tumors? Am J Surg. 2004;187:761-766.
17. Yokoi K, Tanaka N, Shoji K, et al. A study of histopathological assessment criteria for assessing malignancy of gastrointestinal stromal tumor, from a clinical standpoint. J Gastroenterol. 2005;40: 467-473. (Pubitemid 40823281)
18. El-Rifai W, Sarlomo-Rikala M, Andersson LC, et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000;60:3899-3903. (Pubitemid 32204584)
19. Larramendy ML, Tarkkanen M, Blomqvist C, et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 1997;15:1153-1161. (Pubitemid 27424325)
20. Lee J, Li S, Torbenson M, et al. Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases. Cancer Genet Cytogenet. 2004;149:53-57. (Pubitemid 38177558)
21. Whang-Peng J, Knutsen T, Theil K, et al. Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer. 1992;5:299-310.
22. Mott RT, Goodman BK, Burchette JL, et al. Loss of chromosome 13 in a case of soft tissue perineurioma. Clin Neuropathol. 2005;24: 69-76. (Pubitemid 40388665)
23. Weng WH, Lerner M, Grander D, et al. Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity. Int J Oncol. 2005;26:5-16.
24. Michor F. Chromosomal instability and human cancer. Phil Trans R Soc B. 2005;360:631-635.
25. Gagos S, Irminger-Finger I. Chromosome instability in neoplasia: chaotic roots to continuous growth. Int J Biochem Cell Biol. 2005; 37:1014-1033. (Pubitemid 40311743)
26. Michor F, Iwasa Y, Vogelstein B, et al. Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol. 2005;15:43-49.
27. Weinberg RA. The retinoblastoma gene and gene product. In: Levine AJ, ed. Tumour Suppressor Genes, the Cell Cycle, and Cancer. New York: Cold Spring Harbor Laboratory Press; 1992:43-57.
28. Li FP, Abramson DH, Tarone RE, et al. Hereditary retinoblastoma, lipoma and second primary cancers. J Natl Cancer Inst. 1997;89: 83-84. (Pubitemid 26428082)
29. Wurl P, Meye A, Berger D, et al. Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma. Langenbecks Arch Surg. 1998;383:99-103. (Pubitemid 28226347)
30. Hoos A, Lewis JJ, Antonescu CR, et al. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res. 2001;61:3171-3175. (Pubitemid 32691971)
31. Schneider-Stock R, Boltze C, Jaeger V, et al. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas. J Pathol. 2002;197:654-660. (Pubitemid 34906564)
32. Corcoran MM, Hammarsund M, Zhu C, et al. DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer. 2004;40: 285-297. (Pubitemid 38902539)
33. Elnenaei MO, Hamoudi RA, Swansbury J, et al. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer. 2003;36:99-106. (Pubitemid 36077386)
34. van Everdink WJ, Baranova A, Lummen C, et al. RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2003;146:48-57. (Pubitemid 37117434)
35. Ivanov DV, Tyazhelova TV, Lemonnier L, et al. A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Lett. 2003;539: 156-160. (Pubitemid 36351304)
36. Chen C, Bhalala HV, Qiao H, et al. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene. 2002;21:6567-6572. (Pubitemid 35177035)
37. Nemoto Y, Mikami T, Hana K, et al. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1. Pathol Int. 2006;56: 724-731. (Pubitemid 44691158)
38. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52-68. (Pubitemid 40023952)